These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16612881)

  • 1. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Röggla G; Moser B
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):65. PubMed ID: 16612881
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Malliani A
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):63-4. PubMed ID: 16612878
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Mackenzie AF
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):64. PubMed ID: 16612879
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Ricevuti G; Gasparetto C
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):64-5. PubMed ID: 16612880
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioethics, the Surviving Sepsis Campaign, and the industry.
    Wiedermann CJ
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):442-4. PubMed ID: 16091869
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioethics, the Surviving Sepsis Campaign and the industry.
    Bion J; Vincent JL; Angood P
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):63. PubMed ID: 16489529
    [No Abstract]   [Full Text] [Related]  

  • 7. Drotrecogin alfa on trial.
    Tillotson GS
    Lancet Infect Dis; 2009 Jan; 9(1):2-3. PubMed ID: 19095188
    [No Abstract]   [Full Text] [Related]  

  • 8. Kigris. FDA approves first biologic for sepsis.
    Nursing; 2002 Feb; 32(2):18. PubMed ID: 11924158
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks and benefits of activated protein C treatment for severe sepsis.
    Warren HS; Suffredini AF; Eichacker PQ; Munford RS
    N Engl J Med; 2002 Sep; 347(13):1027-30. PubMed ID: 12324562
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing the use of activated protein C in the treatment of severe sepsis.
    Siegel JP
    N Engl J Med; 2002 Sep; 347(13):1030-4. PubMed ID: 12324563
    [No Abstract]   [Full Text] [Related]  

  • 11. Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.
    Eichacker PQ; Natanson C; Danner RL
    N Engl J Med; 2006 Oct; 355(16):1640-2. PubMed ID: 17050887
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe sepsis and therapy with activated protein C.
    Parrillo JE
    N Engl J Med; 2005 Sep; 353(13):1398-400. PubMed ID: 16192486
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond government intervention: drug companies and bioethics.
    Dresser R
    Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855
    [No Abstract]   [Full Text] [Related]  

  • 14. Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial.
    Eichacker PQ; Danner RL; Suffredini AF; Cui X; Natanson C
    Crit Care Med; 2005 Oct; 33(10):2426-8. PubMed ID: 16215410
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated protein C for severe sepsis.
    Ely EW; Bernard GR; Vincent JL
    N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564
    [No Abstract]   [Full Text] [Related]  

  • 16. Activated protein C: do more survive?
    Ridley S
    Intensive Care Med; 2006 Apr; 32(4):608; author reply 610-2. PubMed ID: 16508755
    [No Abstract]   [Full Text] [Related]  

  • 17. Activated protein C: do more survive?
    Macias WL
    Intensive Care Med; 2006 Apr; 32(4):605-7; author reply 610-2. PubMed ID: 16508756
    [No Abstract]   [Full Text] [Related]  

  • 18. [Surgical patient with severe sepsis: activated protein C and Surviving Sepsis Campaign].
    Vallet B; Martin C
    Ann Fr Anesth Reanim; 2005 Apr; 24(4):339-40. PubMed ID: 15826781
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein C may be sepsis solution.
    Garber K
    Nat Biotechnol; 2000 Sep; 18(9):917-8. PubMed ID: 10973198
    [No Abstract]   [Full Text] [Related]  

  • 20. Science, medicine and industry: are we getting out of the black hole in sepsis research?
    Suter PM; Takala J
    Intensive Care Med; 2008 Nov; 34(11):1950-4. PubMed ID: 18839139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.